Asian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MF

Clinical trial NCT01392443 · COMPLETED

Trial details

NCT number: NCT01392443
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis (MF)Post-Polycythemia Vera (PV) MF Post-Essential Thrombocythemia (ET) MF

Start date: 2010-10-14
Primary completion: 2017-10-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.